Pathway Financial Advisers’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,738
Closed -$78.2K 210
2025
Q3
$78.2K Buy
+1,738
New +$76.3K 0.02% 201
2025
Q1
Sell
-1,727
Closed -$65K 231
2024
Q4
$65K Sell
1,727
-68,113
-98% -$2.64M 0.02% 216
2024
Q3
$1.72K Buy
69,840
+68,128
+3,979% +$2.56M ﹤0.01% 357
2024
Q2
$59.2K Buy
1,712
+13
+0.8% +$480 0.02% 218
2024
Q1
$63.9K Buy
1,699
+10
+0.6% +$357 0.02% 213
2023
Q4
$60.6K Buy
1,689
+10
+0.6% +$385 0.02% 214
2023
Q3
$63.4K Buy
+1,679
New +$68.4K 0.03% 215
2023
Q1
$54.4K Sell
1,299
-74
-5% -$3.08K 0.02% 230
2022
Q4
$59.4K Buy
+1,373
New +$54.2K 0.02% 233

Other funds holding EXC

Pathway Financial Advisers's EXC Position: Q4 2025 in Review

Pathway Financial Advisers sold out of Exelon (EXC) in Q4 2025, closing a stake of 1,738 shares — an estimated $78.2K sold.

Pathway Financial Advisers first reported a position in EXC in Q4 2022 and held it in 9 quarters. The position peaked at $78.2K in Q3 2025. 1,249 funds tracked by Wall St. Rank hold EXC as of Q4 2025.

  • Pathway Financial Advisers reported no remaining Exelon position as of Q4 2025 after selling out during the quarter.
  • Pathway Financial Advisers sold 1,738 Exelon shares in Q4 2025, an estimated $78.2K.
  • Pathway Financial Advisers first reported a position in Exelon in Q4 2022 and held it in 9 quarters.
  • Pathway Financial Advisers's Exelon position peaked at $78.2K in Q3 2025.
  • 1,249 funds tracked by Wall St. Rank held Exelon as of Q4 2025.

Based on Pathway Financial Advisers's 13F filing for Q4 2025, filed 6 Feb 2026.